Early Assessment of the Added Value of FDG-PET/CT and MRI-DWI in Monitoring Treatment Response of Stage III Non-Small Cell Lung Cancer

Published
2016
Publication type
Article / Letter to editor
Date issued
2016
Is part of
hdl
1887/117210